Drug Trial Radar · NCT06689514
Study on the Effectiveness of Tranilast in the Treatment of Medium to Large Volume Benign Prostatic Hyperplasia
Last checked: Nov 20, 2026Latest source record: Jan 8, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
30
Planned (sponsor's estimate)
Start
Jan 20, 2025
Primary completion
Dec 31, 2026
Study completion Dec 31, 2026
Sponsor
- Lead sponsor
- Yifeng JingAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Nov 14, 2024
Design
- Study type
- Interventional
- Phase
- Early phase 1
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- Male only, from 55 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Benign prostatic hyperplasia (BPH) is one of the most common urinary and reproductive system diseases in elderly men. The preliminary research of the research group found that mast cells are cells that promote the progression of BPH, and the commonly used mast cell membrane stabilizer and TGF - β pathway inhibitor tranilast significantly inhibited the increase in prostate volume in animal experiments, which is considered to have potential applications in the treatment of BPH. This study plans to include 30 patients with medium to large volume BPH and experimentally explore the efficacy and safety of tranilast in the treatment of medium to large volume BPH.
Conditions
- Prostatic Hypertrophy, Benign
Interventions
alpha receptor antagonistDrug
Oral administration of alpha receptor antagonist (according to the dosage specified in the instructions for treating BPH)
Low dose TranilastDrug
Oral administration of Tranilast Capsules (Qu Ke Shen, Yao Da Pharmaceutical) 100mg TID
High dose TranilastDrug
Oral administration of Tranilast Capsules (Qu Ke Shen, Yao Da Pharmaceutical) 200mg TID
Primary outcomes
What the sponsor says the trial is designed to measure.
- Prostate volumeTime frame: The first month and the sixth month
Locations
2 sites in 1 country. Site status is shown where the registry gives one.
Shanghai General Hospital
Shanghai, China · Not yet recruiting
Shanghai General Hospital
Shanghai, Outside U.S./Canada, China · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.